SCHEMBL6708944

SCHEMBL6708944

O=C(Cc1ccc(F)cc1)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)[nH]c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 1/20 0.39
RXFP1 Q9HBX9 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPT P10636 2/20 0.39
POLB P06746 2/20 0.39
TP53 P04637 1/20 0.39
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC2 Q92769 2/20 0.37
NCOR2 Q9Y618 2/20 0.37
CASP3 P42574 1/20 0.37
PLCG2 P16885 1/20 0.36
KCNMA1 Q12791 1/20 0.36
CA12 O43570 3/20 0.35
CA1 P00915 3/20 0.35
CA2 P00918 3/20 0.35
CA9 Q16790 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707755 0.95 PARP14 (0.43) PARP14MEN1KMT2APOLBTP53
SCHEMBL6707735 0.93 PARP14 (0.43) PARP14RXFP1MEN1KMT2AMAPT
SCHEMBL6708820 0.93 PARP14 (0.41) PARP14MEN1KMT2APOLBTP53
SCHEMBL6708687 0.92 P2RY14 (0.40) PARP14RXFP1MAPTTP53HDAC2
SCHEMBL6709152 0.92 PTK2B (0.42) PARP14MEN1KMT2AMAPTTP53
SCHEMBL6713211 0.91 PARP14 (0.42) PARP14RXFP1MEN1KMT2APOLB
SCHEMBL6712041 0.91 LMNA (0.41) PARP14MEN1KMT2APOLBPLCG2
SCHEMBL6710593 0.91 PARP14 (0.38) PARP14MEN1KMT2AMAPTPOLB
SCHEMBL6707704 0.91 PTK2B (0.39) PARP14MEN1KMT2APOLBPLCG2
SCHEMBL6708857 0.91 GPR35 (0.40) PARP14RXFP1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PARP14 2597/4885RXFP1 3836/4885MEN1 4100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.